Xiaosai Yao
Agency for Science, Technology and Research(SG)Acentech (United States)(US)Kaiser Permanente South San Francisco Medical Center(US)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Hippo pathway signaling and YAP/TAZ, Cancer-related gene regulation, Renal cell carcinoma treatment, Chromatin Remodeling and Cancer
Most-Cited Works
- → VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma(2018)216 cited
- → VHL Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell Carcinoma(2017)180 cited
- → An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance(2023)176 cited
- → Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity(2016)157 cited
- → Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma(2017)69 cited
- → Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma(2018)57 cited